Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EORTC 22971: Chemoradiation for Bladder Cancer
NCT00003642Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 1998
- Primary completion
- Jul 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cisplatin, fluorouracil in bladder cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Oct 1998; status: terminated.
02
Drugs
cisplatinfluorouracil
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00003642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003642.